Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-12-003917
Filing Date
2012-11-08
Accepted
2012-11-08 16:05:39
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 act_10q-093012.htm 10-Q 546791
2 CERTIFICATION act_10q-ex3101.htm EX-31.1 7588
3 CERTIFICATION act_10q-ex3201.htm EX-32.1 3147
  Complete submission text file 0001019687-12-003917.txt   4299415

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE actc-20120930.xml EX-101.INS 520936
5 XBRL SCHEMA FILE actc-20120930.xsd EX-101.SCH 53827
6 XBRL CALCULATION FILE actc-20120930_cal.xml EX-101.CAL 51627
7 XBRL DEFINITION FILE actc-20120930_def.xml EX-101.DEF 144916
8 XBRL LABEL FILE actc-20120930_lab.xml EX-101.LAB 357034
9 XBRL PRESENTATION FILE actc-20120930_pre.xml EX-101.PRE 241308
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
ADVANCED CELL TECHNOLOGY, INC. (Filer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50295 | Film No.: 121190096
SIC: 2834 Pharmaceutical Preparations